Preservation of Haemostasis with Anti-thrombotic Serotonin Antagonism
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 019-025
- https://doi.org/10.29328/journal.jhcr.1001004
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Modulation of Vasoactivity and Platelet Aggregation by Selective 5-HT Receptor Antagonism in HumansJournal of Cardiovascular Pharmacology, 2011
- Discovery and Structure−Activity Relationship of 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine2A Receptor Inverse Agonist for the Treatment of Arterial ThrombosisJournal of Medicinal Chemistry, 2010
- Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisJournal of Thrombosis and Haemostasis, 2010
- Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosisThrombosis and Haemostasis, 2009
- Plasma serotonin levels and the platelet serotonin transporterJournal of Neurochemistry, 2007
- OverviewJournal of Cardiovascular Risk, 1995
- Antagonism of the platelet 5HT2 receptor in the presence of thrombolysisInternational Journal of Cardiology, 1994
- 5HT2-receptors and serotonin release: Their role in human platelet aggregationLife Sciences, 1993
- Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dogCardiovascular Research, 1992
- The involvement of serotonin in the formation of thrombi at critical coronary arterial stenoses in humansCoronary Artery Disease, 1990